Vanda Pharmaceuticals Inc.

IPO

A Global Biopharmaceutical Company

Public · Washington, United States · Founded 2003 · $93.5M raised

Employees
201–500
Founded
2003
Business Model
B2B
Total Funding
$93.5M
Last Round
$93.5M Venture RoundMar 2018
Rounds
1
Type
Public

About

Vanda Pharmaceuticals is a global biopharmaceutical company that develops medicines to improve the lives of patients, using genetics and genomics to inform drug discovery, clinical trials, and commercial positioning. The company received FDA approval for Fanapt (iloperidone), an atypical antipsychotic for schizophrenia, and Hetlioz (tasimelteon), a first-in-class treatment for Non-24-Hour Sleep-Wake Disorder. Vanda also advances pipeline programs including tradipitant for atopic dermatitis and gastroparesis, plus additional tasimelteon indications.

Summary

Vanda Pharmaceuticals Inc. is a Biotech company based in Washington, United States, founded in 2003. It has raised $93.5M in total across 1 round, most recently a $93.5M Venture Round round in Mar 2018.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundMar 2018
$93.5M

Sign up to see all 2 rounds

IPO through Venture Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vanda Pharmaceuticals Inc. on Indexed.vc
<a href="https://indexed.vc/companies/vanda-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/vanda-pharmaceuticals-inc" alt="Vanda Pharmaceuticals Inc. on Indexed.vc" width="260" height="76" /></a>